Related Experiment Video
Updated: Mar 1, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
1.2K
Idiopathic Pulmonary Fibrosis: An Overview
1Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, SW3 6LY London, UK.
British Journal of Hospital Medicine (London, England : 2005)
|February 28, 2026
Summary
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatments. Research aims to improve understanding and management of IPF, offering hope for better therapies and patient outcomes.
Area of Science:
- Pulmonology and Respiratory Medicine
- Pathobiology of Fibrotic Diseases
- Translational Medicine
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with a rising incidence and poor prognosis.
- Current treatments for IPF only slow disease progression, highlighting a significant unmet medical need.
- Lung transplantation offers the only substantial improvement in survival and quality of life for IPF patients.
Purpose of the Study:
- To provide a comprehensive overview of Idiopathic Pulmonary Fibrosis (IPF).
- To summarize current knowledge on IPF definitions, epidemiology, pathobiology, diagnostics, and management strategies.
- To highlight the limitations of existing therapies and the need for novel treatments.
Main Methods:
- Literature review and synthesis of existing research on IPF.
- Analysis of epidemiological data and disease incidence trends.
- Summary of current diagnostic criteria and management guidelines for IPF.
Main Results:
- IPF is characterized by relentless progression, leading to debilitating dyspnea and respiratory failure.
- Average survival post-diagnosis is 3-5 years, underscoring the disease's severity.
- Despite advances in understanding IPF pathobiology, therapeutic options remain limited.
Conclusions:
- There is an urgent need for therapies that can halt or reverse fibrosis in IPF.
- Ongoing research into new therapeutic approaches shows promise for improving IPF outcomes.
- A comprehensive understanding of IPF is crucial for advancing diagnostic and management strategies.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
724
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
724
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:20COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
01:23Cystic Fibrosis: Pathogenesis
953
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
953
01:24Chronic Obstructive Pulmonary Disease
2.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.8K